JW Pharmaceutical 001060
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Trading Information
- Previous Close Price
- ₩27,550.00
- Day Range
- ₩27,350.00–27,850.00
- 52-Week Range
- ₩24,068.63–38,500.00
- Bid/Ask
- ₩27,500.00 / ₩27,600.00
- Market Cap
- ₩649.46 Bil
- Volume/Avg
- 61,932 / 140,316
Key Statistics
- Price/Earnings (Normalized)
- 20.29
- Price/Sales
- 0.86
- Dividend Yield (Trailing)
- 1.45%
- Dividend Yield (Forward)
- 1.45%
- Total Yield
- 1.50%
Company Profile
JW Pharmaceutical is active in the healthcare sector. It has been one of the leading companies in the pharmaceutical market on a global basis. Its original medicine and medical supply pipeline include Livalo, Thrupas, Sigmart and Actemra. It also develops low-protein and low-salt diet food for patients suffering from chronic renal insufficiency as well as general Pharmaceuticals and health care products.
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- Stock Style Box
- Small Core
- Total Number of Employees
- 1,102
- Website
- https://www.jw-pharma.co.kr
Comparables
Valuation
|
Metric
|
001060
|
009420
|
039200
|
|---|---|---|---|
Price/Earnings (Normalized) | 20.29 | 374.30 | — |
Price/Book Value | 2.32 | 12.02 | 16.71 |
Price/Sales | 0.86 | 15.17 | 315.84 |
Price/Cash Flow | 6.31 | — | — |
Price/Earnings
001060
009420
039200
Financial Strength
|
Metric
|
001060
|
009420
|
039200
|
|---|---|---|---|
Quick Ratio | 0.93 | 2.00 | 2.29 |
Current Ratio | 1.34 | 3.14 | 2.37 |
Interest Coverage | 5.15 | −118.68 | −131.58 |
Quick Ratio
001060
009420
039200
Profitability
|
Metric
|
001060
|
009420
|
039200
|
|---|---|---|---|
Return on Assets (Normalized) | 5.78% | −1.76% | −24.13% |
Return on Equity (Normalized) | 14.14% | −2.31% | −31.91% |
Return on Invested Capital (Normalized) | 9.23% | −2.61% | −34.10% |
Return on Assets
001060
009420
039200
Drug Manufacturers - Specialty & Generic Industry Comparables
|
1-Day Chart
|
Name
|
Price
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|---|
| Zoetis Inc Class A
ZTS
| Hcpwthmzmc | Jwzr | $86.1 Bil | |||
| Merck KGaA ADR
MKKGY
| Zsgwlyld | Jtdgg | $74.3 Bil | |||
| Haleon PLC ADR
HLN
| Sgcmmnr | Gqsw | $45.9 Bil | |||
| Viatris Inc
VTRS
| Tnpxhwqr | Wwm | $13.8 Bil | |||
| Dr Reddy's Laboratories Ltd ADR
RDY
| Ndvlwcqd | Psczs | $13.2 Bil | |||
| Catalent Inc
CTLT
| Jdwylpm | Jsvblc | $11.0 Bil | |||
| Prestige Consumer Healthcare Inc
PBH
| Tvjyvhjx | Fzjjzr | $3.4 Bil | |||
| Perrigo Co PLC
PRGO
| Vqxzxbxnj | Ntmx | $3.4 Bil | |||
| Green Thumb Industries Inc
GTBIF
| Blncwpljr | Rtcq | $2.4 Bil | |||
| Curaleaf Holdings Inc
CURLF
| Yjjcqwksc | Nlzpx | $2.2 Bil |
United States